Futurera Pharma-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-07-2024
- Paid Up Capital ₹ 1.00 M
as on 31-07-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -94.51%
(FY 2023)
- Profit 98.31%
(FY 2023)
- Ebitda 98.31%
(FY 2023)
- Net Worth -0.70%
(FY 2023)
- Total Assets 20.66%
(FY 2023)
About Futurera Pharma-Tech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajachandra Viswanadh and Chandra Ayyalasomayajula serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC118949
- Company No.
118949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Futurera Pharma-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajachandra Viswanadh  | Director | 01-Aug-2023 | Current |
| Chandra Ayyalasomayajula | Director | 28-Nov-2018 | Current |
Financial Performance and Corporate Structure Insights of Futurera Pharma-Tech.
Futurera Pharma-Tech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 94.51% decrease. The company also saw a substantial improvement in profitability, with a 98.31% increase in profit. The company's net worth dipped by a decrease of 0.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Futurera Pharma-Tech?
In 2023, Futurera Pharma-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Simplyfi Softech India Private Limited
Active 8 years 2 monthsRajachandra Viswanadh and Chandra Ayyalasomayajula are mutual person
Evionics Innovations Private Limited
Active 5 years 6 daysRajachandra Viswanadh and Chandra Ayyalasomayajula are mutual person
Aykya Formulations Private Limited
Active 3 months 14 daysRajachandra Viswanadh and Chandra Ayyalasomayajula are mutual person
Simplyfi Ai Ventures India Private Limited
Active 6 months 19 daysRajachandra Viswanadh and Chandra Ayyalasomayajula are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Futurera Pharma-Tech?
Unlock and access historical data on people associated with Futurera Pharma-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Futurera Pharma-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Futurera Pharma-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
